Concepedia

Publication | Open Access

Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results

38

Citations

34

References

2023

Year

Abstract

Proprietary or commercial disclosure may be found after the references.

References

YearCitations

Page 1